4//SEC Filing
Orford Keith 4
Accession 0000899243-20-001672
CIK 0001496671other
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 5:56 PM ET
Size
5.5 KB
Accession
0000899243-20-001672
Insider Transaction Report
Form 4
Orford Keith
SR. VP, CLINICAL DEVELOPMENT
Transactions
- Award
Stock Option (Right to Buy)
2020-01-17+140,000→ 140,000 totalExercise: $7.41Exp: 2030-01-17→ Common Stock (140,000 underlying)
Footnotes (1)
- [F1]One-fourth (1/4th) of the Option vests one year after January 17, 2020; the balance of the Option vests in a series of thirty-six (36) successive equal monthly installments thereafter. The Option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company.
Documents
Issuer
Calithera Biosciences, Inc.
CIK 0001496671
Entity typeother
Related Parties
1- filerCIK 0001670740
Filing Metadata
- Form type
- 4
- Filed
- Jan 21, 7:00 PM ET
- Accepted
- Jan 22, 5:56 PM ET
- Size
- 5.5 KB